Hung Whitney Y, Abreu Lanfranco Odaliz
Whitney Y Hung, Department of Pharmacy, Yale New Haven Hospital, New Haven, CT 06510, United States.
World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):405-15. doi: 10.4291/wjgp.v5.i4.405.
Although gallstone and alcohol use have been considered the most common causes of acute pancreatitis, hundreds of frequently prescribed medications are associated with this disease state. The true incidence is unknown since there are few population based studies available. The knowledge of drug induced acute pancreatitis is limited by the availability and the quality of the evidence as the majority of data is extrapolated from case reports. Establishing a definitive causal relationship between a drug and acute pancreatitis poses a challenge to clinicians. Several causative agent classification systems are often used to identify the suspected agents. They require regular updates since new drug induced acute pancreatitis cases are reported continuously. In addition, infrequently prescribed medications and herbal medications are often omitted. Furthermore, identification of drug induced acute pancreatitis with new medications often requires accumulation of post market case reports. The unrealistic expectation for a comprehensive list of medications and the multifactorial nature of acute pancreatitis call for a different approach. In this article, we review the potential mechanisms of drug induced acute pancreatitis and provide the perspective of deductive reasoning in order to allow clinicians to identify potential drug induced acute pancreatitis with limited data.
尽管胆结石和酒精摄入一直被认为是急性胰腺炎最常见的病因,但数百种常用处方药都与这种疾病状态有关。由于基于人群的研究很少,其真实发病率尚不清楚。药物性急性胰腺炎的相关知识受到证据的可得性和质量的限制,因为大多数数据是从病例报告中推断出来的。确定药物与急性胰腺炎之间明确的因果关系对临床医生来说是一项挑战。几种致病因素分类系统经常用于识别可疑因素。由于不断有新的药物性急性胰腺炎病例报告,它们需要定期更新。此外,不常用的药物和草药往往被遗漏。此外,识别新药引起的药物性急性胰腺炎通常需要积累上市后病例报告。对全面的药物清单的不切实际期望以及急性胰腺炎的多因素性质需要一种不同的方法。在本文中,我们回顾了药物性急性胰腺炎的潜在机制,并提供演绎推理的观点,以便临床医生能够在数据有限的情况下识别潜在的药物性急性胰腺炎。